Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
about
Osteosarcoma: Current Treatment and a Collaborative Pathway to SuccessTransport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cellsNeoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trialComparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.New advances in surgical oncologyOsteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma.The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patientsThe expression and significance of IDH1 and p53 in osteosarcomaOsteosarcoma in children 5 years of age or younger at initial diagnosisDoes increased rate of limb-sparing surgery affect survival in osteosarcoma?Current treatment of osteosarcoma.Current treatment of high grade osteosarcoma of the extremity: review.Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcomaThe efficacy of high-dose versus moderate-dose chemotherapy in treating osteosarcoma: a systematic review and meta-analysisEn block surgery for osteogenic sarcoma: analysis and review of ninety operative casesSurgical management of osteogenic sarcoma of the lower limb.Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model.Chemotherapy for osteosarcoma.Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience.Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults.A radiotherapy technique to improve dose homogeneity around bone prosthesesFunction and quality-of-life of survivors of pelvic and lower extremity osteosarcoma and Ewing's sarcoma: the Childhood Cancer Survivor Study.Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI.Population pharmacokinetics of high-dose methotrexate after intravenous administration in Chinese osteosarcoma patients from a single institutionL-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.Survival trends in osteosarcoma of humerus.Clinical value of ezrin expression in primary osteosarcoma.Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.How can survival be improved in localized osteosarcoma?
P2860
Q26797555-A8E6850A-0FEF-494B-BDE9-27CF1AB92176Q28569608-BD82B4E7-A371-4F3D-A914-84CBCC9A1FDFQ32100844-F755A220-DF4A-43A4-AF9D-41C6FAD47E46Q33393253-38F9429C-12A3-4917-83EC-59BEF598A6E4Q33395803-5E8A8DEA-5C97-4B80-A508-3AFAFE24C430Q33555060-5946747D-A11B-4702-A021-83FCB6B16AB7Q33605514-8DBC4BE0-2613-43C7-9E8C-DA1B8AE90801Q33735680-9E905DA5-EF2E-4E00-9A56-B65BCB8AC444Q33744672-670B8B2F-2400-4CA8-BEDA-17DCE6EFF3B9Q33860309-FDA627A9-CF22-43FF-A861-EA0EDD4646C2Q33864108-F6E03809-8575-44CC-9561-46A0B79F61FBQ34049526-BFC6D428-6F90-450B-9DF5-D501C9D9CA6AQ34164575-0AB3F0E1-A174-4DCE-B3CF-43FD17B605C9Q34242261-66D0CD73-00FC-42DA-98CA-39EB65BBF0C5Q34307165-622CC005-6DAE-444E-834B-F13895BB9C0EQ34589401-4DCF5DD8-FE94-490B-AB79-DC0A7761027CQ34627906-1BEF29B7-9781-4E39-BBAB-155AEB2A2887Q34628840-702D6C9B-0F1F-4008-A55E-5D02ADF08F81Q35138344-80F02130-0BB0-46CA-A55B-D0179C0ABFD3Q35190158-65F01344-F109-4FD9-9034-2330FE777F09Q35858388-80F15767-4D50-4447-AC19-CFF79782B52EQ35876682-987A1E09-C1F5-454C-AFBD-E21013AA1543Q35877186-DFF7D041-2CC4-4269-918F-4F4367794D8CQ36126820-07F53A4B-F04A-4A4D-930F-61F2B3C2649EQ36467151-01C1D2A3-6739-4EDE-935A-5795314BBD5FQ36486421-7B992459-CAC9-4F39-87D4-2EDAB31AC2C6Q36556924-1D56B4F0-5734-4E7C-A3F2-583D23481B4CQ36657784-EC4A4D97-36AE-4485-9CA1-2641F9681786Q36674384-5AF1DA18-A2B0-4C86-B5AE-59811F3A2FCDQ36696559-D6BFD8CA-56F8-4D3A-8D39-BE6876AE1003Q36750627-20D2F741-8D9E-42EB-B525-B49840A23D1AQ36816150-DADFEAD0-87C5-489D-A1BF-916682A8D010Q36853886-374C033B-EEB8-4A85-BC9A-9810F6C5AA65Q37047540-F51B05EE-DE40-42BF-9B84-F4BD6BE0D699Q37141239-3AF5DD83-FB6C-485F-B0C3-585D6D71CC10Q37376890-2C545DF1-805A-43F7-AD5C-1A904C9EE05CQ37471124-0D7338A5-C60D-4352-AA5D-9248CFF140CAQ37560522-1AE6D5E1-DD65-491D-9FD1-16CBCB2E57F4Q37705293-4C173B48-4D23-4820-97A6-3FF0D7B27141Q37782098-FB5BC392-D5E3-4CB1-915D-D80D00690E4C
P2860
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@en
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@nl
type
label
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@en
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@nl
prefLabel
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@en
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@nl
P2093
P1433
P1476
Primary osteogenic sarcoma: th ...... motherapy and delayed surgery.
@en
P2093
P304
P356
10.1002/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S
P407
P577
1979-06-01T00:00:00Z